Feige, Katharina, Roth, Sebastian, M'Pembele, Rene, Galow, Anna, Koenig, Sarah, Stroethoff, Martin, Raupach, Annika, Lurati Buse, Giovanna, Mathes, Alexander M., Hollmann, Markus W., Huhn, Ragnar and Torregroza, Carolin (2022). Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning-A Translational Approach. Int. J. Mol. Sci., 23 (23). BASEL: MDPI. ISSN 1422-0067

Full text not available from this repository.

Abstract

The adverse impact of common diseases like diabetes mellitus and acute hyperglycemia on morbidity and mortality from myocardial infarction (MI) has been well documented over the past years of research. In the clinical setting, the relationship between blood glucose and mortality appears linear, with amplifying risk associated with increasing blood glucose levels. Further, this seems to be independent of a diagnosis of diabetes. In the experimental setting, various comorbidities seem to impact ischemic and pharmacological conditioning strategies, protecting the heart against ischemia and reperfusion injury. In this translational experimental approach from bedside to bench, we set out to determine whether acute and/or prolonged hyperglycemia have an influence on the protective effect of transferred human RIPC-plasma and, therefore, might obstruct translation into the clinical setting. Control and RIPC plasma of young healthy men were transferred to isolated hearts of young male Wistar rats in vitro. Plasma was administered before global ischemia under either short hyperglycemic (HGs Con, HGs RIPC) conditions, prolonged hyperglycemia (HGl Con, HGl RIPC), or under normoglycemia (Con, RIPC). Infarct sizes were determined by TTC staining. Control hearts showed an infarct size of 55 +/- 7%. Preconditioning with transferred RIPC plasma under normoglycemia significantly reduced infarct size to 25 +/- 4% (p < 0.05 vs. Con). Under acute hyperglycemia, control hearts showed an infarct size of 63 +/- 5%. Applying RIPC plasma under short hyperglycemic conditions led to a significant infarct size reduction of 41 +/- 4% (p < 0.05 vs. HGs Con). However, the cardioprotective effect of RIPC plasma under normoglycemia was significantly stronger compared with acute hyperglycemic conditions (RIPC vs. HGs RIPC; p < 0.05). Prolonged hyperglycemia (HGl RIPC) completely abolished the cardioprotective effect of RIPC plasma (infarct size 60 +/- 7%; p < 0.05 vs. HGl Con; HGl Con 59 +/- 5%).

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Feige, KatharinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Roth, SebastianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
M'Pembele, ReneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Galow, AnnaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koenig, SarahUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stroethoff, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Raupach, AnnikaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lurati Buse, GiovannaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mathes, Alexander M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hollmann, Markus W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Huhn, RagnarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Torregroza, CarolinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-674673
DOI: 10.3390/ijms232314557
Journal or Publication Title: Int. J. Mol. Sci.
Volume: 23
Number: 23
Date: 2022
Publisher: MDPI
Place of Publication: BASEL
ISSN: 1422-0067
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ACUTE MYOCARDIAL-INFARCTION; K-ATP CHANNELS; RAT-HEART; ISCHEMIA/REPERFUSION INJURY; STRESS HYPERGLYCEMIA; OUTCOMES; GLUCOSE; REPERFUSION; DEATH; RISKMultiple languages
Biochemistry & Molecular Biology; Chemistry, MultidisciplinaryMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/67467

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item